← Crisis Orb

Public health

MRSA bloodstream infection resistance

MRSA রক্তপ্রবাহ সংক্রমণে প্রতিরোধ

Near-term outlook

MRSA bloodstream infection resistance is classified Critical at 78.0%, observed through 2023-12-31. That observation is about 2.8 years old. Assessment basis: MRSA bloodstream infections, not all antimicrobial resistance.

Evidence observed through 2023-12-31, about 2.8 years old (one observation per reference year, published about a year after the year ends).

MRSA bloodstream infections (% resistant)

78.0%

Source: World Health Organization, Global Health Observatory · Observed through 2023-12-31

Assessment

Critical

BDPolicyLab analytical classification based on the stated assessment basis. It is not an official agency designation. Benchmark stress score: 95/100.

Observed through

2023-12-31

Latest valid evidence date, about 2.8 years old.

Source: BDPolicyLab Crisis Orb · Updated 2026-10-11

Evidence

Evidence Reading Observed through Primary source
MRSA bloodstream infections (% resistant) 78.0% 2023-12-31 World Health Organization, Global Health ObservatoryAMR_INFECT_MRSA
Methodology and validation

The assessment compares the latest source observation with BDPolicyLab analytical monitoring bands. For this detector, higher readings indicate greater stress; the internal analytical cutoffs are 25.0%, 35.0%, 50.0%, 70.0%. The score is a level-anchored piecewise-linear transformation with state bands at 20, 40, 60, and 85. The indicator's primary source is identified with the evidence in this card. Forecast ranges are published only as calibrated 80% predictive intervals with an explicit source time unit.

BDPolicyLab analytical classification based on the stated assessment basis. It is not an official agency designation.

No public forecast is shown because the validation or time-unit requirement was not met.

Sources: World Health Organization, Global Health Observatory